Abstract
When discussing treatment with patients, doctors may not mention newly licensed drugs that are not yet funded by healthcare schemes. Although their motives are good, the ethics are questionable
Publication types
-
Research Support, Non-U.S. Gov't
-
Review
MeSH terms
-
Australia
-
Drug Costs
-
Ethics, Medical
-
Family Practice / economics
-
Family Practice / ethics
-
Health Services Accessibility
-
Humans
-
Paternalism*
-
Patient Education as Topic
-
Patient Participation
-
Pharmaceutical Preparations / economics*
-
Pharmaceutical Preparations / supply & distribution
Substances
-
Pharmaceutical Preparations